Author:
Harshfield Eric L.,Fauman Eric B.,Stacey David,Paul Dirk S.,Ziemek Daniel,Ong Rachel M. Y.,Danesh John,Butterworth Adam S.,Rasheed Asif,Sattar Taniya,Zameer-ul-Asar ,Saleem Imran,Hina Zoubia,Ishtiaq Unzila,Qamar Nadeem,Mallick Nadeem Hayat,Yaqub Zia,Saghir Tahir,Rizvi Syed Nadeem Hasan,Memon Anis,Ishaq Mohammad,Rasheed Syed Zahed,Memon Fazal-ur-Rehman,Jalal Anjum,Abbas Shahid,Frossard Philippe,Saleheen Danish,Wood Angela M.,Griffin Julian L.,Koulman Albert
Abstract
Abstract
Background
Genetic, lifestyle, and environmental factors can lead to perturbations in circulating lipid levels and increase the risk of cardiovascular and metabolic diseases. However, how changes in individual lipid species contribute to disease risk is often unclear. Moreover, little is known about the role of lipids on cardiovascular disease in Pakistan, a population historically underrepresented in cardiovascular studies.
Methods
We characterised the genetic architecture of the human blood lipidome in 5662 hospital controls from the Pakistan Risk of Myocardial Infarction Study (PROMIS) and 13,814 healthy British blood donors from the INTERVAL study. We applied a candidate causal gene prioritisation tool to link the genetic variants associated with each lipid to the most likely causal genes, and Gaussian Graphical Modelling network analysis to identify and illustrate relationships between lipids and genetic loci.
Results
We identified 253 genetic associations with 181 lipids measured using direct infusion high-resolution mass spectrometry in PROMIS, and 502 genetic associations with 244 lipids in INTERVAL. Our analyses revealed new biological insights at genetic loci associated with cardiometabolic diseases, including novel lipid associations at the LPL, MBOAT7, LIPC, APOE-C1-C2-C4, SGPP1, and SPTLC3 loci.
Conclusions
Our findings, generated using a distinctive lipidomics platform in an understudied South Asian population, strengthen and expand the knowledge base of the genetic determinants of lipids and their association with cardiometabolic disease-related loci.
Funder
British Heart Foundation
Medical Research Council
Wellcome Trust
Sixth Framework Programme
Pfizer
Novartis
Merck
NHS Blood and Transplant
National Institute for Health Research
Publisher
Springer Science and Business Media LLC